• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与严重 SARS-CoV-2 感染后相关的休止期脱发:临床特征和我们的治疗经验。

Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.

机构信息

Department of Clinical and Molecular Sciences - Dermatological Clinic, Università Politecnica delle Marche, Ancona, Italy.

Dipartimento di Scienze Biomediche e Sanità Pubblica, Clinica Malattie Infettive, Università Politecnica delle Marche, Ancona, Italy.

出版信息

Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.

DOI:10.1111/dth.14547
PMID:33190397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7744849/
Abstract

Telogen effluvium (TE) is one of the most common form of hair loss in women. Many triggers have been identified, as stress, drugs, trauma, endocrine disease, nutritional deficiencies, and febrile states. We report three cases of TE occurred after severe Sars-Cov-2 infection and provide our clinical management, according to Sars-Cov-2 hygiene measures. Only one case report has been found in the literature associating anagen effluvium during severe Sars-Cov-2 infection. Other studies reported the exacerbation of a preexisting TE, correlated to the stress of lockdown. In our cases, patients never had a TE diagnosis before and did not report previous evident hair loss. TE can be associated with post severe Sars-Cov-2 infection. From our revision of the literature, this is the first case-series describing TE in post severe Sars-Cov-2 patients. Further studies are needed to evaluate the relationship between TE and Sars-Cov-2 infection.

摘要

休止期脱发(TE)是女性最常见的脱发形式之一。已经确定了许多诱因,如压力、药物、创伤、内分泌疾病、营养缺乏和发热状态。我们报告了三例严重 SARS-CoV-2 感染后发生的 TE,并根据 SARS-CoV-2 卫生措施提供了我们的临床管理。文献中仅发现一例报告将严重 SARS-CoV-2 感染期间的生长期脱发与之相关联。其他研究报告了先前存在的 TE 的恶化,与封锁期间的压力有关。在我们的病例中,患者以前从未被诊断出 TE,也没有报告以前明显的脱发。TE 可能与严重 SARS-CoV-2 感染后有关。根据我们对文献的复习,这是首例描述严重 SARS-CoV-2 后患者 TE 的病例系列。需要进一步研究来评估 TE 与 SARS-CoV-2 感染之间的关系。

相似文献

1
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.与严重 SARS-CoV-2 感染后相关的休止期脱发:临床特征和我们的治疗经验。
Dermatol Ther. 2021 Jan;34(1):e14547. doi: 10.1111/dth.14547. Epub 2020 Nov 23.
2
COVID-19 induced telogen effluvium.COVID-19 引发的休止期脱发。
Dermatol Ther. 2021 Nov;34(6):e15175. doi: 10.1111/dth.15175. Epub 2021 Nov 6.
3
Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management.严重急性呼吸综合征冠状病毒 2 感染后脱发的管理:对病理生理学的深入了解及其对更好管理的意义。
J Dermatol. 2022 Oct;49(10):939-947. doi: 10.1111/1346-8138.16475. Epub 2022 May 27.
4
Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.红色发光二极管光疗法治疗患有和不患有雄激素性脱发的长期新冠患者的休止期脱发
Ann Agric Environ Med. 2024 Jun 27;31(2):239-247. doi: 10.26444/aaem/177238. Epub 2024 Jan 8.
5
Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?大流行期间休止期脱发患者的评估:单核细胞是否是新冠后休止期脱发的原因?
J Cosmet Dermatol. 2022 May;21(5):1809-1815. doi: 10.1111/jocd.14883. Epub 2022 Feb 28.
6
The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染及其疫苗在各类脱发中的作用
Dermatol Ther. 2022 Jun;35(6):e15433. doi: 10.1111/dth.15433. Epub 2022 Apr 1.
7
COVID-19 infection is a major cause of acute telogen effluvium.COVID-19 感染是急性休止期脱发的主要原因。
Ir J Med Sci. 2022 Aug;191(4):1677-1681. doi: 10.1007/s11845-021-02754-5. Epub 2021 Aug 31.
8
[Review of the post-COVID-19 syndrome associated to acute telogen effluvium].[与急性休止期脱发相关的新冠后综合征综述]
Rev Med Inst Mex Seguro Soc. 2023 Jul 31;61(4):496-501. doi: 10.5281/zenodo.8200471.
9
Post-COVID Telogen Effluvium.新冠后休止期脱发
Acta Dermatovenerol Croat. 2022 Dec;30(4):220-226.
10
Telogen effluvium associated with COVID-19 infection.与 COVID-19 感染相关的休止期脱发。
Dermatol Ther. 2021 Mar;34(2):e14761. doi: 10.1111/dth.14761. Epub 2021 Jan 14.

引用本文的文献

1
Telogen Effluvium Following Coronavirus Disease-2019 Infection: A Retrospective Study of 113 Cases.2019冠状病毒病感染后的休止期脱发:113例回顾性研究
Int J Trichology. 2025 Jan-Feb;17(1):32-35. doi: 10.4103/ijt.ijt_38_22. Epub 2025 Jun 23.
2
Relationship Between Anemia and Telogen Effluvium in Post-COVID-19 Survivors.新冠康复者中贫血与休止期脱发的关系
Dermatol Pract Concept. 2025 Jan 30;15(1):4234. doi: 10.5826/dpc.1501a4234.
3
The impact, prevalence, and association of different forms of hair loss among individuals with anxiety disorder: Systematic review and meta-analysis.焦虑症患者中不同形式脱发的影响、患病率及相关性:系统评价与荟萃分析。
Medicine (Baltimore). 2025 Feb 7;104(6):e41457. doi: 10.1097/MD.0000000000041457.
4
The Difference Between SARS-CoV-2 Associated Telogen Effluvium and Telogen Effluvium Due to Other Causes.新型冠状病毒相关休止期脱发与其他原因导致的休止期脱发之间的差异
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024170. doi: 10.5826/dpc.1403a170.
5
Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.新冠后休止期脱发:血清铁蛋白生物标志物的诊断价值和膳食补充剂的预防价值。一项病例对照研究。
Arch Dermatol Res. 2024 Jun 6;316(6):336. doi: 10.1007/s00403-024-03004-1.
6
The impact of different antibiotic injection regimens on patients with severe infections: A meta-analysis.不同抗生素注射方案对重症感染患者的影响:一项荟萃分析。
Int Wound J. 2024 Jan;21(1):e14514. doi: 10.1111/iwj.14514.
7
A Cross-Sectional Study on Post-Coronavirus Disease (COVID-19) Hair Loss at a Tertiary Care Hospital.某三级护理医院关于冠状病毒病(COVID-19)后脱发的横断面研究
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023263. doi: 10.5826/dpc.1304a263.
8
[Review of the post-COVID-19 syndrome associated to acute telogen effluvium].[与急性休止期脱发相关的新冠后综合征综述]
Rev Med Inst Mex Seguro Soc. 2023 Jul 31;61(4):496-501. doi: 10.5281/zenodo.8200471.
9
SARS-CoV-2 Infection-A Trigger Factor for Telogen Effluvium: Review of the Literature with a Case-Based Guidance for Clinical Evaluation.新型冠状病毒感染——休止期脱发的触发因素:文献综述及基于病例的临床评估指南
Life (Basel). 2023 Jul 18;13(7):1576. doi: 10.3390/life13071576.
10
The Effect of Covid-19 on the Hair Diseases Observed in Health Care Providers: Analysis of 513 Participants.新冠病毒对医护人员所患毛发疾病的影响:对513名参与者的分析。
Dermatol Pract Concept. 2023 Jan 1;13(1):e2023036. doi: 10.5826/dpc.1301a36.

本文引用的文献

1
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era.重启时间:新冠疫情时代二级医院皮肤科门诊恢复诊疗活动方案
Int J Dermatol. 2020 Nov;59(11):1411-1413. doi: 10.1111/ijd.15187. Epub 2020 Sep 23.
2
COVID-19 related anagen effluvium.COVID-19 相关生长期脱发。
J Dermatolog Treat. 2022 Mar;33(2):1114-1115. doi: 10.1080/09546634.2020.1792400. Epub 2020 Jul 16.
3
Evaluation of the effects of COVID-19 pandemic on hair diseases through a web-based questionnaire.通过网络问卷评估 COVID-19 大流行对头发疾病的影响。
Dermatol Ther. 2020 Nov;33(6):e13923. doi: 10.1111/dth.13923. Epub 2020 Jul 16.
4
Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems.揭开新冠病毒细胞因子风暴之谜:从皮肤到器官系统。
Dermatol Ther. 2020 Nov;33(6):e13859. doi: 10.1111/dth.13859. Epub 2020 Jul 7.
5
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic.我该如何照顾你?皮肤科医生在新冠疫情期间满足患者需求。
Dermatol Ther. 2020 Jul;33(4):e13740. doi: 10.1111/dth.13740. Epub 2020 Jun 30.
6
Management of telogen effluvium during the COVID-19 emergency: Psychological implications.新冠疫情期间休止期脱发的管理:心理影响
Dermatol Ther. 2020 Jul;33(4):e13648. doi: 10.1111/dth.13648. Epub 2020 Jun 5.
7
Active implications for dermatologists in 'SARS-CoV-2 ERA': Personal experience and review of literature.皮肤科医生在“新冠疫情时代”的积极意义:个人经验与文献回顾。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):1626-1632. doi: 10.1111/jdv.16646.
8
COVID-19-associated immune thrombocytopenia.新型冠状病毒肺炎相关免疫性血小板减少症
Br J Haematol. 2020 Jul;190(2):e61-e64. doi: 10.1111/bjh.16850. Epub 2020 Jun 8.
9
Skin involvement in SARS-CoV-2 infection: Case series.新型冠状病毒2型感染中的皮肤表现:病例系列
J Med Virol. 2020 Nov;92(11):2332-2334. doi: 10.1002/jmv.26012. Epub 2020 Jun 2.
10
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.